Tehran-Sana
The Iranian company (Zarrin Teb Mashreq Zamin) revealed that it has produced two plant-based drugs to treat people infected with the Corona virus.
According to the Iranian news agency IRNA, the two drugs were subjected to clinical trials in Tehran and showed good efficacy in treating people infected with the Corona virus, as the drug (Formula Astragalus ZMZ), licensed by the Iranian Food and Drug Administration, helps improve the symptoms of Corona patients, such as body pain, coughing and shortness of breath. (Relang ZMZ) is also licensed by the department to relieve symptoms of the disease.
Iran is working on the development and production of many local vaccines against the Corona virus, as it announced in the middle of last month the completion of clinical trials for the joint Iranian-Australian vaccine (Spikogin).
